Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$242.49 - $301.46 $363,735 - $452,189
1,500 Added 78.95%
3,400 $835,000
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $1.66 Million - $2.51 Million
-7,400 Reduced 79.57%
1,900 $470,000
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $720,850 - $952,354
-2,600 Reduced 21.85%
9,300 $3.08 Million
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $1.11 Million - $1.37 Million
-3,700 Reduced 23.72%
11,900 $4.27 Million
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $496,304 - $601,920
1,600 Added 11.43%
15,600 $5.08 Million
Q2 2021

Aug 16, 2021

SELL
$262.71 - $351.17 $998,297 - $1.33 Million
-3,800 Reduced 21.35%
14,000 $4.37 Million
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $1.37 Million - $1.7 Million
4,800 Added 36.92%
17,800 $5.67 Million
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $604,512 - $778,080
2,400 Added 22.64%
13,000 $4.22 Million
Q3 2020

Nov 16, 2020

BUY
$255.22 - $317.0 $306,264 - $380,400
1,200 Added 12.77%
10,600 $2.94 Million
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $339,360 - $617,015
2,400 Added 34.29%
9,400 $2.27 Million
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $326,275 - $490,025
-2,500 Reduced 26.32%
7,000 $1.02 Million
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $908,067 - $1.27 Million
-5,700 Reduced 37.5%
9,500 $1.62 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $633,204 - $1.01 Million
3,600 Added 31.03%
15,200 $2.7 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $677,592 - $769,338
2,700 Added 30.34%
11,600 $3.02 Million
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $690,975 - $905,625
2,500 Added 39.06%
8,900 $2.54 Million
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $1.29 Million - $2.04 Million
4,600 Added 255.56%
6,400 $2.08 Million
Q3 2018

Nov 14, 2018

BUY
$354.53 - $449.75 $638,154 - $809,550
1,800 New
1,800 $810,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.